| Application no. and date | 11820517.8 (espacenet) (Federated) (European Patent Register), 20110823 | | Patent/reg. no. and date | DK/EP 2608670, 20181031 | | Publication date | 20130703 | | Priority no. and date | US 376120 P, 20100823 | | EP pub. no. and date |
EP 2608670 20130703 | | Effective date | | | Applicant/owner | Alkermes Pharma Ireland Limited, Connaught House
1 Burlington Road
Dublin 4, IE | | Applicant ref. no. | V1812-071-DK | | Inventor | DEAVER, Daniel, 4 Maple Brook Lane
Franklin
MA 02038, US,
TODTENKOPF, Mark, 4 Stephen Way
Franklin
MA 02038, US | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A01N 43/42 (2006.01) , A61K 31/44 (2006.01) , A61K 31/485 (2006.01) , A61P 3/04 (2006.01) | | Title | FREMGANGSMÅDE TIL BEHANDLING AF ANTIPSYKOTIKUM-INDUCERET VÆGTSTIGNING | | Int. application no. | US2011048794 | | Int. publication no. | WO2012027359 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
